Reduced Ejection Fraction

1

Review clinical trials related to Reduced Ejection Fraction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction

This study aims to evaluate the effect of sacubitril/valsartan in patients with prosthetic heart valves with heart failure with reduced ejection fraction (HFrEF).

Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: Sep 30, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years old. [+3]

Hemodynamic instability. [+9]